組み換えタンパク質の世界市場レポート 2025年

組み換えタンパク質市場規模は、今後数年で急成長が見込まれます。2029年にはCAGR13.7％で43億米ドルに成長します。予測期間の成長は、個別化医療の採用拡大、バイオテクノロジー分野の急速な拡大、希少疾患への世界の取り組み、タンパク質工学技術の進歩、新興市場、未開拓機会などに起因すると考えられます。予測期間における世界の動向としては、個別化医療の拡大、バイオテクノロジー分野の急成長、治療用タンパク質の需要、新規治療ターゲットの出現、ワクチン開発への世界の注力などが挙げられます。

個別化医療の重視の高まりは、今後数年間、組換えタンパク質市場の成長を促進すると予想されます。個別化医療とは、より効果的で的を絞ったヘルスケア成果の達成を目指し、各患者のユニークな特性、遺伝、ニーズに基づいて治療や療法をカスタマイズする医療アプローチです。個別化医療の成長は、個人の遺伝子プロファイルに合わせた治療を可能にするゲノム技術とデータ分析の進歩によるところが大きいです。組み換えタンパク質は、患者固有の遺伝的・分子的プロファイルを標的としたオーダーメイド治療の開発を可能にし、治療効果を高め、副作用を最小限に抑えることで、個別化医療において重要な役割を果たしています。例えば、2024年2月、米国の非営利団体である個別化医療連合（Personalized Medicine Coalition）は、2023年にFDAが希少疾患患者のために16の新しい個別化治療を承認したと報告しました。その結果、個別化医療への注目の高まりが組換えタンパク質市場の拡大に寄与しています。

ヘルスケアの研究開発における政府のイニシアチブは、組み換えタンパク質市場の成長に貢献すると期待されています。様々な政府当局が、組み換えタンパク質の調査を含むヘルスケアイニシアチブを支援するための具体的な行動やプログラムを実施しています。2022年、英国政府はヘルスケアの研究と製造を後押しするために2億6,000万英ポンドの資金提供を発表し、NHS主導のヘルスケア研究、診断、治療開発を支援しています。ヘルスケアにおける研究開発のための政府のイニシアチブは、組換えタンパク質市場を前進させる上で重要な役割を果たしています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界組み換えタンパク質PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、制約）
• 最終用途産業の分析
• 世界の組み換えタンパク質市場：成長率分析
• 世界の組み換えタンパク質市場の実績：規模と成長, 2019-2024
• 世界の組み換えタンパク質市場の予測：規模と成長, 2024-2029, 2034F
• 世界組み換えタンパク質総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の組み換えタンパク質市場：製品別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 抗体
• サイトカイン
• 免疫チェックポイントタンパク質
• ウイルス抗原
• 酵素
• 組み換え調節タンパク質
• ホルモン
• その他の製品
• 世界の組み換えタンパク質市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 医薬品および創薬開発
• 治療薬
• 調査
• その他の用途
• 世界の組み換えタンパク質市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 製薬およびバイオテクノロジー企業
• 学術調査機関
• 診断検査室
• その他のエンドユーザー
• 世界の組み換えタンパク質市場抗体のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• モノクローナル抗体
• ポリクローナル抗体
• 世界の組み換えタンパク質市場サイトカインの種類によるサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• インターロイキン
• インターフェロン
• 腫瘍壊死因子（TNF）
• 世界の組み換えタンパク質市場、免疫チェックポイントタンパク質のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• PD-1またはPD-L1阻害剤
• CTLA-4阻害剤
• 世界の組み換えタンパク質市場、ウイルス抗原のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ウイルスカプシドタンパク質
• エンベロープタンパク質
• 世界の組み換えタンパク質市場、酵素のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 制限酵素
• ポリメラーゼ
• リガーゼ
• 世界の組み換えタンパク質市場、組換え調節タンパク質のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 転写因子
• 受容体
• ホルモン
• 世界の組み換えタンパク質市場ホルモンの種類によるサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• インスリン
• 成長ホルモン
• 世界の組み換えタンパク質市場、その他の製品のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 融合タンパク質
• ペプチド治療

第7章 地域別・国別分析

• 世界の組み換えタンパク質市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の組み換えタンパク質市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 組み換えタンパク質市場：競合情勢
• 組み換えタンパク質市場：企業プロファイル
  • Abcam plc Overview, Products and Services, Strategy and Financial Analysis
  • Abnova Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Bio-Rad Laboratoroies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Merck Co. & KGaA Overview, Products and Services, Strategy and Financial Analysis
  • R&D Systems Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Proteintech Group Inc.
• RayBiotech Life Inc.
• GenScript Biotech Corporation
• Elpiscience Biopharmaceuticals Co. Ltd.
• Elevian Inc.
• Gigagen Inc.
• Janssen-Cilag Pvt. Ltd.
• Sino Biological Inc.
• OriGene Technologies Inc.
• Feldan Therapeutics Inc.
• Randox Laboratories Ltd.
• Bio-Techne Corporation
• Thermo Fisher Scientific Inc.
• PerkinElmer Inc.
• Crown Bioscience Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 組み換えタンパク質市場2029：新たな機会を提供する国
• 組み換えタンパク質市場2029：新たな機会を提供するセグメント
• 組み換えタンパク質市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Recombinant proteins are proteins that have been altered or edited using recombinant DNA technology. In this process, a plasmid is employed, containing the gene encoding the desired target protein, which is cloned downstream of a promoter region. These modified proteins find application in various fields, including pharmaceuticals, protein-based polymers for drug delivery, disease treatment through antibodies and enzymes, protein scaffolds for tissue engineering, and numerous other uses.

The primary types of recombinant protein products encompass antibodies, cytokines, immune checkpoint proteins, virus antigens, enzymes, recombinant regulatory proteins, hormones, and others. Antibodies, for example, are immune system components that circulate in the blood, identifying and neutralizing foreign objects such as bacteria and viruses. They are utilized across diverse applications, including drug and discovery development, therapeutics, research, and more. These recombinant proteins are predominantly utilized by pharmaceutical and biotechnology companies, academic and research institutes, diagnostic laboratories, and other relevant entities.

The recombinant proteins market research report is one of a series of new reports from The Business Research Company that provides recombinant proteins market statistics, including recombinant proteins industry global market size, regional shares, competitors with a recombinant proteins market share, detailed recombinant proteins market segments, market trends and opportunities, and any further data you may need to thrive in the recombinant proteins industry. The recombinant proteins market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The recombinant proteins market size has grown rapidly in recent years. It will grow from $2.31 billion in 2024 to $2.57 billion in 2025 at a compound annual growth rate (CAGR) of 11.3%. The growth in the historic period can be attributed to increasing demand for biopharmaceuticals, rising prevalence of chronic diseases, growing aging population, government initiatives and funding, expanding applications in research and diagnostics.

The recombinant proteins market size is expected to see rapid growth in the next few years. It will grow to $4.3 billion in 2029 at a compound annual growth rate (CAGR) of 13.7%. The growth in the forecast period can be attributed to increased adoption of personalized medicine, rapid expansion of the biotechnology sector, global efforts to address rare diseases, advancements in protein engineering techniques, emerging markets, and untapped opportunities. Major trends in the forecast period include expansion of personalized medicine, rapid growth in the biotechnology sector, demand for therapeutic proteins, emergence of novel therapeutic targets, global focus on vaccine development.

The increasing emphasis on personalized medicine is expected to drive the growth of the recombinant protein market in the coming years. Personalized medicine is a medical approach that customizes treatments and therapies based on the unique characteristics, genetics, and needs of each patient, aiming to achieve more effective and targeted healthcare outcomes. The growth of personalized medicine is largely due to advancements in genomic technologies and data analytics, which allow for treatments tailored to individual genetic profiles. Recombinant proteins play a crucial role in personalized medicine by enabling the development of customized therapies that target a patient's specific genetic and molecular profile, enhancing treatment efficacy and minimizing side effects. For example, in February 2024, the Personalized Medicine Coalition, a U.S.-based non-profit organization, reported that the FDA approved 16 new personalized treatments for patients with rare diseases in 2023, a significant rise from the six approvals in 2022. As a result, the growing focus on personalized medicine is contributing to the expansion of the recombinant protein market.

Government initiatives in healthcare research and development are expected to contribute to the growth of the recombinant protein market. Various government authorities are undertaking specific actions and programs to support healthcare initiatives, including research into recombinant proteins. In 2022, the UK government announced £260 million in funding to boost healthcare research and manufacturing, supporting NHS-led health research, diagnostics, and treatment development. Government initiatives for research and development in healthcare play a crucial role in driving the recombinant protein market forward.

Product innovation emerges as a prominent trend in the recombinant protein market, with major companies focusing on developing cutting-edge products to enhance their market positions. For instance, ProteoGenix introduced the XtenCHO Transient CHO Expression System in March 2022, aiming to improve biologics development. This system offers significant advantages, including higher yields, optimized plasmid stability, and streamlined protocols for enhanced efficiency in bioanalytical applications and drug development.

Collaborations and partnerships are strategic initiatives undertaken by major companies in the recombinant protein market to gain a competitive edge. In October 2023, ARTES Biotechnology GmbH collaborated with Basic Pharma to establish a streamlined supply chain process for developing and producing non-GMP recombinant proteins. This collaboration focuses on expediting the time-to-market for new pharmaceutical products, showcasing the potential benefits of partnerships in fostering innovation.

In March 2022, Fujifilm, a Japan-based technology and manufacturing company, acquired Shenandoah Biotechnology for an undisclosed sum. The purpose of this acquisition is to enhance Fujifilm's position as a key partner for pharmaceutical clients in the growing advanced therapies market by providing a comprehensive source of cGMP cell culture solutions. Shenandoah Biotechnology, a U.S.-based biotechnology company, specializes in producing recombinant proteins, including cytokines and growth factors, which are essential for various life science applications such as drug discovery, research, and cell and gene therapies.

Major companies operating in the recombinant proteins market include Abcam plc, Abnova Corporation, Bio-Rad Laboratoroies Inc., Merck Co. & KGaA, R&D Systems Inc., Proteintech Group Inc., RayBiotech Life Inc., GenScript Biotech Corporation, Elpiscience Biopharmaceuticals Co. Ltd., Elevian Inc., Gigagen Inc., Janssen- Cilag Pvt. Ltd., Sino Biological Inc., OriGene Technologies Inc., Feldan Therapeutics Inc., Randox Laboratories Ltd., Bio-Techne Corporation, Thermo Fisher Scientific Inc., PerkinElmer Inc., Crown Bioscience Inc., Airway Therapeutics Inc., Amgen Inc., Aviva Systems Biology Corp., Eli Lilly and Company

North America was the largest region in the recombinant protein market in 2024. The regions covered in the recombinant proteins market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the recombinant proteins market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The recombinant protein market consists of sales of recombinant monoclonal antibodies, interferons, and interleukins. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Recombinant Proteins Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on recombinant proteins market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for recombinant proteins ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The recombinant proteins market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Antibodies; Cytokines; Immune Checkpoint Protein; Virus Antigens; Enzymes; Recombinant Regulatory Proteins; Hormones; Other Products
• 2) By Application: Drug And Discovery Development; Therapeutics; Research; Other Applications
• 3) By End User: Pharmaceutical And Biotechnology Companies; Academic And Research Institute; Diagnostic Laboratories; Other End Users
• Subsegments:
• 1) By Antibodies: Monoclonal Antibodies; Polyclonal Antibodies
• 2) By Cytokines: Interleukins; Interferons; Tumor Necrosis Factors (TNFs)
• 3) By Immune Checkpoint Proteins: PD-1 Or PD-L1 Inhibitors; CTLA-4 Inhibitors
• 4) By Virus Antigens: Viral Capsid Proteins; Envelope Proteins
• 5) By Enzymes: Restriction Enzymes; Polymerases; Ligases
• 6) By Recombinant Regulatory Proteins: Transcription Factors; Receptors; Hormones
• 7) By Hormones: Insulin; Growth Hormones
• 8) By Other Products: Fusion Proteins; Peptide Therapeutics
• Companies Mentioned: Abcam plc; Abnova Corporation; Bio-Rad Laboratoroies Inc.; Merck Co. & KGaA; R&D Systems Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Recombinant Proteins Market Characteristics

3. Recombinant Proteins Market Trends And Strategies

4. Recombinant Proteins Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Recombinant Proteins Growth Analysis And Strategic Analysis Framework

• 5.1. Global Recombinant Proteins PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Recombinant Proteins Market Growth Rate Analysis
• 5.4. Global Recombinant Proteins Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Recombinant Proteins Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Recombinant Proteins Total Addressable Market (TAM)

6. Recombinant Proteins Market Segmentation

• 6.1. Global Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Antibodies
• Cytokines
• Immune Checkpoint Protein
• Virus Antigens
• Enzymes
• Recombinant Regulatory Proteins
• Hormones
• Other Products
• 6.2. Global Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Drug And Discovery Development
• Therapeutics
• Research
• Other Applications
• 6.3. Global Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pharmaceutical And Biotechnology Companies
• Academic And Research Institute
• Diagnostic Laboratories
• Other End Users
• 6.4. Global Recombinant Proteins Market, Sub-Segmentation Of Antibodies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Monoclonal Antibodies
• Polyclonal Antibodies
• 6.5. Global Recombinant Proteins Market, Sub-Segmentation Of Cytokines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Interleukins
• Interferons
• Tumor Necrosis Factors (TNFs)
• 6.6. Global Recombinant Proteins Market, Sub-Segmentation Of Immune Checkpoint Proteins, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• PD-1 Or PD-L1 Inhibitors
• CTLA-4 Inhibitors
• 6.7. Global Recombinant Proteins Market, Sub-Segmentation Of Virus Antigens, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Viral Capsid Proteins
• Envelope Proteins
• 6.8. Global Recombinant Proteins Market, Sub-Segmentation Of Enzymes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Restriction Enzymes
• Polymerases
• Ligases
• 6.9. Global Recombinant Proteins Market, Sub-Segmentation Of Recombinant Regulatory Proteins, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Transcription Factors
• Receptors
• Hormones
• 6.10. Global Recombinant Proteins Market, Sub-Segmentation Of Hormones, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Insulin
• Growth Hormones
• 6.11. Global Recombinant Proteins Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Fusion Proteins
• Peptide Therapeutics

7. Recombinant Proteins Market Regional And Country Analysis

• 7.1. Global Recombinant Proteins Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Recombinant Proteins Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Recombinant Proteins Market

• 8.1. Asia-Pacific Recombinant Proteins Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Recombinant Proteins Market

• 9.1. China Recombinant Proteins Market Overview
• 9.2. China Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Recombinant Proteins Market

• 10.1. India Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Recombinant Proteins Market

• 11.1. Japan Recombinant Proteins Market Overview
• 11.2. Japan Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Recombinant Proteins Market

• 12.1. Australia Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Recombinant Proteins Market

• 13.1. Indonesia Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Recombinant Proteins Market

• 14.1. South Korea Recombinant Proteins Market Overview
• 14.2. South Korea Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Recombinant Proteins Market

• 15.1. Western Europe Recombinant Proteins Market Overview
• 15.2. Western Europe Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Recombinant Proteins Market

• 16.1. UK Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Recombinant Proteins Market

• 17.1. Germany Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Recombinant Proteins Market

• 18.1. France Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Recombinant Proteins Market

• 19.1. Italy Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Recombinant Proteins Market

• 20.1. Spain Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Recombinant Proteins Market

• 21.1. Eastern Europe Recombinant Proteins Market Overview
• 21.2. Eastern Europe Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Recombinant Proteins Market

• 22.1. Russia Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Recombinant Proteins Market

• 23.1. North America Recombinant Proteins Market Overview
• 23.2. North America Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Recombinant Proteins Market

• 24.1. USA Recombinant Proteins Market Overview
• 24.2. USA Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Recombinant Proteins Market

• 25.1. Canada Recombinant Proteins Market Overview
• 25.2. Canada Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Recombinant Proteins Market

• 26.1. South America Recombinant Proteins Market Overview
• 26.2. South America Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Recombinant Proteins Market

• 27.1. Brazil Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Recombinant Proteins Market

• 28.1. Middle East Recombinant Proteins Market Overview
• 28.2. Middle East Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Recombinant Proteins Market

• 29.1. Africa Recombinant Proteins Market Overview
• 29.2. Africa Recombinant Proteins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Recombinant Proteins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Recombinant Proteins Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Recombinant Proteins Market Competitive Landscape And Company Profiles

• 30.1. Recombinant Proteins Market Competitive Landscape
• 30.2. Recombinant Proteins Market Company Profiles
  • 30.2.1. Abcam plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Abnova Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Bio-Rad Laboratoroies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Merck Co. & KGaA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. R&D Systems Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Recombinant Proteins Market Other Major And Innovative Companies

• 31.1. Proteintech Group Inc.
• 31.2. RayBiotech Life Inc.
• 31.3. GenScript Biotech Corporation
• 31.4. Elpiscience Biopharmaceuticals Co. Ltd.
• 31.5. Elevian Inc.
• 31.6. Gigagen Inc.
• 31.7. Janssen- Cilag Pvt. Ltd.
• 31.8. Sino Biological Inc.
• 31.9. OriGene Technologies Inc.
• 31.10. Feldan Therapeutics Inc.
• 31.11. Randox Laboratories Ltd.
• 31.12. Bio-Techne Corporation
• 31.13. Thermo Fisher Scientific Inc.
• 31.14. PerkinElmer Inc.
• 31.15. Crown Bioscience Inc.

32. Global Recombinant Proteins Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Recombinant Proteins Market

34. Recent Developments In The Recombinant Proteins Market

35. Recombinant Proteins Market High Potential Countries, Segments and Strategies

• 35.1 Recombinant Proteins Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Recombinant Proteins Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Recombinant Proteins Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer